Silo Pharma Inc (SILO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -931 | -3,038 | -2,248 | -1,614 | -239 |
| Depreciation Amortization | 101 | 847 | 728 | 485 | 83 |
| Other Working Capital | 473 | -87 | -20 | -20 | 39 |
| Other Operating Activity | 38 | 1,121 | 918 | 809 | 0 |
| Operating Cash Flow | $-319 | $-1,157 | $-621 | $-340 | $-118 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 31 | 39 | 20 | 15 | 0 |
| Investing Cash Flow | $31 | $39 | $20 | $15 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2 | 54 | 54 | 54 | N/A |
| Debt Repayment | N/A | -35 | -35 | -35 | N/A |
| Common Stock Issued | N/A | 2,116 | 2,116 | 2,114 | N/A |
| Other Financing Activity | 3,794 | 0 | 0 | 0 | 15 |
| Financing Cash Flow | $3,797 | $2,135 | $2,135 | $2,133 | $15 |
| Beginning Cash Position | 1,128 | 112 | 112 | 112 | 112 |
| End Cash Position | 4,637 | 1,128 | 1,646 | 1,919 | 9 |
| Net Cash Flow | $3,508 | $1,017 | $1,534 | $1,808 | $-103 |
| Free Cash Flow | |||||
| Operating Cash Flow | -319 | -1,157 | -621 | -340 | -118 |
| Free Cash Flow | -319 | -1,157 | -621 | -340 | -118 |